Amisulpride is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Reference standards of Amisulpride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Amisulpride (IPRS/69/13)-from IPC [catalogue_number] => PA IPIPRS 69 13 [category_ids] => ,151, [chemical_name] => [weight] => NA [form] => [cas] => NA [pslug] => amisulpride-iprs-69-13-paipiprs6913 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA IPIPRS 69 13
CAS :
Molecular Formula :
Molecular Weight : NA
stdClass Object ( [pname] => Amisulpride (IPRS/73/19) - from IPC [catalogue_number] => PA IPRS 73 19 [category_ids] => ,151, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => amisulpride-iprs-73-19-paiprs7319 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA IPRS 73 19
Molecular Formula : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
